MicroRNAs as biomarkers for CNS disease

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Neurological disease diagnosis relies on late-stage symptoms and imaging.
• Early molecular changes, involving non-coding RNA networks, precede clinical manifestation.
• Direct brain tissue access for molecular analysis is often limited.

Purpose of the Study:

• To explore the potential of extracellular RNA (exRNA) as biomarkers for early detection of neurological and psychiatric conditions.
• To review the possibilities and challenges associated with using microRNA and other small RNAs in diagnostics.

Main Methods:

• Review of current literature on exRNA profiling and sequencing technologies.
• Analysis of exRNA secretion mechanisms by central nervous system (CNS) cells.
• Investigation of exRNA as potential biomarkers for CNS malignancies and neurodegenerative diseases.

Main Results:

• Extracellular microRNAs and small non-coding RNAs are secreted by CNS cells via exosomes and other vesicles.
• Advanced sequencing technologies enable detection of virtually all RNA species from minimal biological samples.
• Extracellular RNA shows promise as a biomarker for various brain disorders, including malignancies and neurodegenerative conditions.

Conclusions:

• Extracellular RNA profiling represents a significant advancement for presymptomatic disease detection.
• The use of peripheral exRNA may reflect central nervous system pathological processes, aiding diagnosis.
• Further research is needed to overcome challenges and establish exRNA as a reliable diagnostic signature for neuropsychiatric disorders.